Klinikum Chemnitz

Tumour stage distribution and survival of malignant melanoma in Germany 2002-2011 (2016) Schoffer O, Schuelein S, Arand G, Arnholdt H, Baaske D, Bargou RC, Becker N, et al. Journal article Hematopoietic cell transplantation in patients with intermediate and high-risk AML: results from the randomized Study Alliance Leukemia (SAL) AML 2003 trial (2015) Schetelig J, Schaich M, Schaefer-Eckart K, Haenel M, Aulitzky WE, Einsele H, Schmitz N, et al. Journal article Impact of unbalanced minor route versus major route karyotypes at diagnosis on prognosis of CML (2015) Fabarius A, Kalmanti L, Dietz CT, Lauseker M, Rinaldetti S, Haferlach C, Goehring G, et al. Journal article Addition of sorafenib versus placebo to standard therapy in patients aged 60 years or younger with newly diagnosed acute myeloid leukaemia (SORAML): a multicentre, phase 2, randomised controlled trial (2015) Rollig C, Serve H, Huettmann A, Noppeney R, Mueller-Tidow C, Krug U, Baldus CD, et al. Journal article Allogeneic Stem-Cell Transplantation in Patients With NPM1-Mutated Acute Myeloid Leukemia: Results From a Prospective Donor Versus No-Donor Analysis of Patients After Upfront HLA Typing Within the SAL-AML 2003 Trial (2015) Roellig C, Bornhaeuser M, Kramer M, Thiede C, Ho AD, Kraemer A, Schaefer-Eckart K, et al. Journal article Velocity of early BCR-ABL transcript elimination as an optimized predictor of outcome in chronic myeloid leukemia (CML) patients in chronic phase on treatment with imatinib (2014) Hanfstein B, Shlyakhto V, Lauseker M, Hehlmann R, Saussele S, Dietz C, Erben P, et al. Journal article Neoadjuvant short-course radiotherapy followed by chemotherapy or simultaneous radiochemotherapy for local unresectable rectal cancer (2014) Klautke G, Sauer R Journal article Older patients with chronic myeloid leukemia (>=65 years) profit more from higher imatinib doses than younger patients: a subanalysis of the randomized CML-Study IV (2014) Proetel U, Pletsch N, Lauseker M, Müller MC, Hanfstein B, Krause S, Kalmanti L, et al. Journal article, Original article Distinct characteristics of e13a2 versus e14a2 BCR-ABL1 driven chronic myeloid leukemia under first-line therapy with imatinib (2014) Hanfstein B, Lauseker M, Hehlmann R, Saussele S, Erben P, Dietz C, Fabarius A, et al. Journal article Older patients with inoperable non-small cell lung cancer: long-term survival after concurrent chemoradiotherapy (2014) Semrau S, Zettl H, Hildebrandt G, Klautke G, Fietkau R Journal article